BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28841414)

  • 21. FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
    Fu X; Jeselsohn R; Pereira R; Hollingsworth EF; Creighton CJ; Li F; Shea M; Nardone A; De Angelis C; Heiser LM; Anur P; Wang N; Grasso CS; Spellman PT; Griffith OL; Tsimelzon A; Gutierrez C; Huang S; Edwards DP; Trivedi MV; Rimawi MF; Lopez-Terrada D; Hilsenbeck SG; Gray JW; Brown M; Osborne CK; Schiff R
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):E6600-E6609. PubMed ID: 27791031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative Binding of Transcription Factors Orchestrates Reprogramming.
    Chronis C; Fiziev P; Papp B; Butz S; Bonora G; Sabri S; Ernst J; Plath K
    Cell; 2017 Jan; 168(3):442-459.e20. PubMed ID: 28111071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between a new HNF3 and the HNF1 transcriptional factors in the duck hepatitis B virus enhancer.
    Crescenzo-Chaigne B; Pillot J; Lilienbaum A
    Virology; 1995 Oct; 213(1):231-40. PubMed ID: 7483267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tex10: A New Player in the Core Pluripotency Circuitry.
    Buganim Y
    Cell Stem Cell; 2015 Jun; 16(6):572-3. PubMed ID: 26046753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression.
    Zhao JC; Fong KW; Jin HJ; Yang YA; Kim J; Yu J
    Oncogene; 2016 Aug; 35(33):4335-44. PubMed ID: 26751772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1.
    Tong Z; Meng X; Wang J; Wang L
    Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pioneer Transcription Factor FoxA Maintains an Accessible Nucleosome Configuration at Enhancers for Tissue-Specific Gene Activation.
    Iwafuchi-Doi M; Donahue G; Kakumanu A; Watts JA; Mahony S; Pugh BF; Lee D; Kaestner KH; Zaret KS
    Mol Cell; 2016 Apr; 62(1):79-91. PubMed ID: 27058788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancer decommissioning by Snail1-induced competitive displacement of TCF7L2 and down-regulation of transcriptional activators results in EPHB2 silencing.
    Schnappauf O; Beyes S; Dertmann A; Freihen V; Frey P; Jägle S; Rose K; Michoel T; Grosschedl R; Hecht A
    Biochim Biophys Acta; 2016 Nov; 1859(11):1353-1367. PubMed ID: 27504909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXA and master transcription factors recruit Mediator and Cohesin to the core transcriptional regulatory circuitry of cancer cells.
    Fournier M; Bourriquen G; Lamaze FC; Côté MC; Fournier É; Joly-Beauparlant C; Caron V; Gobeil S; Droit A; Bilodeau S
    Sci Rep; 2016 Oct; 6():34962. PubMed ID: 27739523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-level expression of forkhead-box protein A1 in metastatic prostate cancer.
    Jain RK; Mehta RJ; Nakshatri H; Idrees MT; Badve SS
    Histopathology; 2011 Apr; 58(5):766-72. PubMed ID: 21401706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factor cooperativity in early adipogenic hotspots and super-enhancers.
    Siersbæk R; Rabiee A; Nielsen R; Sidoli S; Traynor S; Loft A; Poulsen LC; Rogowska-Wrzesinska A; Jensen ON; Mandrup S
    Cell Rep; 2014 Jun; 7(5):1443-1455. PubMed ID: 24857652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner.
    Bretschneider N; Brand H; Miller N; Lowery AJ; Kerin MJ; Gannon F; Denger S
    Cancer Res; 2008 Jan; 68(1):106-14. PubMed ID: 18172302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance.
    Tasdemir N; Banito A; Roe JS; Alonso-Curbelo D; Camiolo M; Tschaharganeh DF; Huang CH; Aksoy O; Bolden JE; Chen CC; Fennell M; Thapar V; Chicas A; Vakoc CR; Lowe SW
    Cancer Discov; 2016 Jun; 6(6):612-29. PubMed ID: 27099234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of hepatitis B virus ENI enhancer activity by hepatocyte-enriched transcription factor HNF3.
    Chen M; Hieng S; Qian X; Costa R; Ou JH
    Virology; 1994 Nov; 205(1):127-32. PubMed ID: 7975208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.
    Zhao MT; Shao NY; Hu S; Ma N; Srinivasan R; Jahanbani F; Lee J; Zhang SL; Snyder MP; Wu JC
    Circ Res; 2017 Nov; 121(11):1237-1250. PubMed ID: 29030344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXA1 defines cancer cell specificity.
    Zhang G; Zhao Y; Liu Y; Kao LP; Wang X; Skerry B; Li Z
    Sci Adv; 2016 Mar; 2(3):e1501473. PubMed ID: 27034986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXA1 inhibits prostate cancer neuroendocrine differentiation.
    Kim J; Jin H; Zhao JC; Yang YA; Li Y; Yang X; Dong X; Yu J
    Oncogene; 2017 Jul; 36(28):4072-4080. PubMed ID: 28319070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer.
    Gerhardt J; Montani M; Wild P; Beer M; Huber F; Hermanns T; Müntener M; Kristiansen G
    Am J Pathol; 2012 Feb; 180(2):848-61. PubMed ID: 22138582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1.
    Shen SQ; Huang LS; Xiao XL; Zhu XF; Xiong DD; Cao XM; Wei KL; Chen G; Feng ZB
    Oncol Rep; 2017 Jul; 38(1):368-376. PubMed ID: 28534958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.